Last reviewed · How we verify
Adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
Approved treatments
- Prandin · Novo Nordisk
Repaglinide lowers blood glucose levels by stimulating insulin release from the pancreas through ATP-dependent potassium channel blockade.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus patent landscape — cliff calendar, originator estates, attackable patents
- Adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus treatment landscape brief
- Adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus treatment updates RSS
Frequently asked questions about Adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
What drugs treat Adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus?
Tracked treatments include Prandin.
What is the treatment for Adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus?
Standard treatment for Adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus includes Prandin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus patent cliff · Adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus CI report
- Treatment: Prandin · Novo Nordisk
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing